ClassID:

21017

A61K38/40 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Transferrins, e.g. lactoferrins, ovotransferrins

Recent Application in this class:
#301
20130136796
2013-05-30

Acellular bioabsorbable tissue regeneration matrices

#302
20130115267
2013-05-09

COMPOSITIONS AND METHODS FOR REDUCING EDEMA

#303
20130071372
2013-03-21

Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof

#304
20130064809
2013-03-14

Antimicrobial composition and uses thereof

#305
20130064804
2013-03-14

BIO-REPLENISHMENT (BioRep) FOR IMPROVING SLEEP ARCHITECTURE

#306
20130064803
2013-03-14

BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH

#307
20130058873
2013-03-07

P97 fragments with transfer activity

#308
20130045287
2013-02-21

Treatment for Concussion using Gallium Compounds

#309
20130039903
2013-02-14

ECZEMA TREATMENT

#310
20130035477
2013-02-07

Removing endotoxin from proteins

#311
20130034542
2013-02-07

COLD TREATMENT

#312
20130034541
2013-02-07

PHARMACEUTICAL COMPOSITIONS

#313
20130022584
2013-01-24

Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof

#314
20120328537
2012-12-27

Topical wound management formulation

#315
20120308644
2012-12-06

Compositions for mucosal delivery of agents

#316
20120301485
2012-11-29

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

#317
20120294826
2012-11-22

METHODS, KITS AND COMPOSITIONS FOR AMELIORATING ADVERSE EFFECTS ASSOCIATED WITH TRANSFUSION OF AGED RED BLOOD CELLS

#318
20120276126
2012-11-01

LACTOFERRIN IN THE TREATMENT OF MALIGNANT NEOPLASMS AND OTHER HYPERPROLIFERATIVE DISEASES

#319
20120270777
2012-10-25

Lactoferrin and gut neuronal health in adults and/or elderly

#320
20120263656
2012-10-18

Natural polypeptides for oral health care

#321
20120245080
2012-09-27

MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE

#322
20120244157
2012-09-27

USE OF TNF-ALPHA INHIBITORS FOR TREATING A NERVE DISORDER MEDIATED BY NUCLEUS PULPOSUS

#323
20120238747
2012-09-20

Transfection reagents

#324
20120237495
2012-09-20

Method of treatment using solubilized protein composition obtained from eggshell membrane

#325
20120220517
2012-08-30

Glycopegylation methods and proteins/peptides produced by the methods

#326
20120219526
2012-08-30

NUTRITIONAL COMPOSITIONS COMPRISING LACTOFERRIN AND PROBIOTICS AND KITS OF PARTS THEREOF

#327
20120207712
2012-08-16

Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin

#328
20120184484
2012-07-19

Lactoferrin and brain health and development in infants

#329
20120184483
2012-07-19

Lactoferrin and neuronal health and development in the infant gut

#330
20120177610
2012-07-12

Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins

#331
20120172288
2012-07-05

USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO DISEASES AND CONDITIONS

#332
20120171231
2012-07-05

USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN STIMULATING IMMUNE CELLS

#333
20120171176
2012-07-05

Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract

#334
20120171164
2012-07-05

USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO VIRAL RESPIRATORY TRACT INFECTIONS

#335
20120171163
2012-07-05

METHOD FOR INHIBITING A BACTERIAL INVASIVE MECHANISM USING A NUTRITIONAL COMPOSITION

#336
20120156190
2012-06-21

Influenza prevention and treatment composition

#337
20120148541
2012-06-14

COMPOSITIONS AND METHODS TO GENERATE PILOSEBACEOUS UNITS

#338
20120142583
2012-06-07

Methods of inhibiting and treating bacterial biofilms by metal chelators

#339
20120129780
2012-05-24

LACTOFERRIN AND BRAIN HEALTH AND PROTECTION IN ADULTS

#340
20120122767
2012-05-17

Lactoferrin-based biomaterials for tissue regeneration and drug delivery

#341
20120094915
2012-04-19

ANTI-MENTAL FATIGUE DRUG

#342
20120093816
2012-04-19

Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus

#343
20120088729
2012-04-12

Non-glycosylated transferrin expressed in monocots

#344
20120070423
2012-03-22

ORAL COMPOSITION AND METHOD OF FORMING AND USING SAME

#345
20120064176
2012-03-15

Composition for preventing and treating fatty liver

#346
20120034177
2012-02-09

METHOD OF WHITENING SKIN

#347
20120028882
2012-02-02

Method for removing endotoxin from proteins

#348
20120021071
2012-01-26

Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis

#349
20110306565
2011-12-15

HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION

#350
20110300229
2011-12-08

TREATING OR PREVENTING ROTAVIRUS INFECTION

#351
20110293749
2011-12-01

Surgical adjuvant composition and associated methods of use

#352
20110286986
2011-11-24

Lactoferrin and angiogenin compositions and uses thereof

#353
20110243952
2011-10-06

COMPOUND AND METHOD FOR REGULATING PLASMINOGEN ACTIVATION AND CELL MIGRATION

#354
20110229521
2011-09-22

NUTRITIONAL SUPPORT OF THE IMMUNE SYSTEM DURING ANTI-CANCER TREATMENT

#355
20110229447
2011-09-22

NUTRITIONAL SUPPORT TO PREVENT OR MODERATE BONE MARROW PARALYSIS OR NEUTROPENIA DURING ANTI-CANCER TREATMENT

#356
20110224266
2011-09-15

4 aminopyridine and a pharmaceutical composition for treatment of neuronal disorders

#357
20110223136
2011-09-15

Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor

#358
20110212107
2011-09-01

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

#359
20110200575
2011-08-18

Metallo-lactoferrin-coenzyme compositions to improve sleep patterns

#360
20110190204
2011-08-04

Taxane- and taxoid-protein compositions

#361
20110189239
2011-08-04

Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

#362
20110182943
2011-07-28

METHODS OF IMMUNE OR HEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER, CANCER SYMPTOMS, OR THE SYMPTOMS OF CANCER TREATMENTS

#363
20110182914
2011-07-28

METHODS AND COMPOSITIONS

#364
20110182874
2011-07-28

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#365
20110182873
2011-07-28

Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#366
20110177050
2011-07-21

Methods comprising serratia peptidase for inhibition of osteomyelitis

#367
20110177049
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#368
20110177048
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis

#369
20110172160
2011-07-14

Heat-stable, aqueous lactoferrin composition and its preparation and use

#370
20110171189
2011-07-14

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

#371
20110129454
2011-06-02

Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#372
20110123576
2011-05-26

INTESTINAL ENVIRONMENT-IMPROVING AGENT

#373
20110117184
2011-05-19

Compositions for mucosal delivery of agents

#374
20110091561
2011-04-21

Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer

#375
20110076295
2011-03-31

Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases

#376
20110076253
2011-03-31

Defined culture conditions of human embryonic stem cells

#377
20110059062
2011-03-10

USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN AIRWAY PASSAGES

#378
20110038917
2011-02-17

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING GRAM-NEGATIVE BACTERIAL INFECTIONS

#379
20110034401
2011-02-10

Process for solubilizing protein from a proteinaceous material and compositions thereof

#380
20110033440
2011-02-10

Solubilized protein composition obtained from avian eggshell membrane

#381
20110020434
2011-01-27

NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS

#382
20110015120
2011-01-20

Pharmaceutical and cosmetic compositions including lactoferrin, ciclopirox, etidronic acid

#383
20110014279
2011-01-20

BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF

#384
20110009467
2011-01-13

Methods to increase or decrease bone density

#385
20110008402
2011-01-13

SOULUBLE B-N-ACETYLGLUCOSEAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF

#386
20110008361
2011-01-13

Treatment Method

#387
20100329995
2010-12-30

COMPOSITIONS CONTAINING LACTOFERRIN, AND METHODS OF USING SAME TO PROMOTE GROWTH OF SKIN CELLS

#388
20100322872
2010-12-23

NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS

#389
20100316621
2010-12-16

PROPHYLATIC AGENT FOR AUTOIMMUNE DISEASE

#390
20100310673
2010-12-09

Method of imparting heat resistance to lactoferrin

#391
20100310545
2010-12-09

Dry treatment mixture and methods of production and use

#392
20100305048
2010-12-02

NOVEL USE OF CYTOKINE INHIBITORS

#393
20100298208
2010-11-25

Biofilm prevention using lactoferrin

#394
20100285103
2010-11-11

MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF

#395
20100272708
2010-10-28

METHOD FOR THE TREATMENT OF TYPE AND TYPE IV HYPERSENSITIVITY

#396
20100272697
2010-10-28

PANCREATIC ISLET CELLS COMPOSITION AND METHODS

#397
20100239558
2010-09-23

Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases

#398
20100234329
2010-09-16

INGESTIBLE FILM COMPOSITION

#399
20100221359
2010-09-02

Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin

#400
20100215767
2010-08-26

SKIN WHITENING AGENT

#401
20100215699
2010-08-26

LACTOFERRIN AS A RADIOPROTECTIVE AGENT

#402
20100215631
2010-08-26

ANTI-INFLAMMATORY COMPOSITION COMPRISING GLYCINE AND LACTOFERRIN AND THE USE THEREOF

#403
20100210510
2010-08-19

ORAL LACTOFERRIN IN THE TREATMENT OF SEPSIS

#404
20100209411
2010-08-19

USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS

#405
20100204447
2010-08-12

Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis

#406
20100183581
2010-07-22

Compositions and methods for modulating blood-brain barrier transport

#407
20100166807
2010-07-01

Methods for reducing the incidence of mastitis

#408
20100159593
2010-06-24

Transfection reagents

#409
20100150922
2010-06-17

Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus

#410
20100150897
2010-06-17

Compositions and methods for enzymatic treatment of lung disorders

#411
20100144598
2010-06-10

Natural polypeptides for oral health care

#412
20100137208
2010-06-03

INTRATUMORALLY ADMINISTERED LACTOFERRIN IN THE TREATMENT OF MALIGNANTNEOPLASMS AND OTHER HYPERPROLIFERATIVE DISEASES

#413
20100111920
2010-05-06

METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES EMPLOYING PEROXIDE-PRODUCING ENZYMES AND PEROXIDASES

#414
20100105070
2010-04-29

Diagnosis and treatment of preeclampsia

#415
20100092497
2010-04-15

METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER

#416
20100087851
2010-04-08

Methods and compositions for sealing and adhering biological tissues and medical uses thereof

#417
20100068803
2010-03-18

Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof

#418
20100048456
2010-02-25

Glycopegylation methods and proteins/peptides produced by the methods

#419
20100041606
2010-02-18

Methods of Use of Eggshell Polypeptides

#420
20100041139
2010-02-18

Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof

#421
20100034824
2010-02-11

TARGETED BIOCIDES

#422
20100029564
2010-02-04

Solubilized protein composition obtained from eggshell membrane

#423
20100022442
2010-01-28

COMPOSITIONS AND METHODS FOR INCREASING SERUM ANTIOXIDANT CONCENTRATIONS, DECREASING SERUM TRIGLYCERIDE LEVELS, INHIBITING INSULIN-RECEPTOR SIGNALING ACTIVITY, INCREASING SERUM GHRELIN LEVELS, AND DECREASING SERUM TNF-ALPHA LEVELS

#424
20100015051
2010-01-21

Transferrin-conjugated nanoparticles for increasing efficacy of a therapeutic agent

#425
20100009014
2010-01-14

Use of composition for manufacture of medicant and method for inhibiting formation of body fat

#426
20100003347
2010-01-07

Composition for preventing and treating fatty liver

#427
20100003235
2010-01-07

ORAL FORMULATIONS FOR ENTERIC DISORDERS AND/OR REHYDRATION

#428
20090318334
2009-12-24

Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease

#429
20090317484
2009-12-24

Salivary substitute

#430
20090317378
2009-12-24

Antimicrobial composition and uses thereof

#431
20090317372
2009-12-24

SMALL MOLECULES FOR THE REDUCTION OF HIGH BLOOD GLUCOSE LEVEL

#432
20090291122
2009-11-26

Wound Care Treatment Product

#433
20090270309
2009-10-29

USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES

#434
20090227502
2009-09-10

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

#435
20090215693
2009-08-27

METHODS FOR INCREASING HYALURONIC ACID LEVELS AND IMPROVING MOISTURE RETENTION IN TISSUE

#436
20090202574
2009-08-13

METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER

#437
20090163311
2009-06-25

Series spring blade tensioner

#438
20090157046
2009-06-18

Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof

#439
20090156484
2009-06-18

Methods of treating destructive inflammation of the mucous membranes with lactoferrin

#440
20090149379
2009-06-11

Methods for reduction of adhesion formation using cytokine inhibitors

#441
20090148433
2009-06-11

Metallo-protein and tocotrienol (MP-T3) compositions and uses thereof

#442
20090143583
2009-06-04

Transfection reagents

#443
20090142298
2009-06-04

Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C

#444
20090130191
2009-05-21

Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin

#445
20090104210
2009-04-23

Peptide compounds for treating obesity and insulin resistance

#446
20090104173
2009-04-23

Process for solubilizing protein from a proteinaceous material and compositions thereof

#447
20090082269
2009-03-26

AGENT FOR AMELIORATING HEAVY METAL-INDUCED DISORDERS, AND MEDICINAL COMPOSITION, FOOD AND COSMETIC CONTAINING THE SAME

#448
20090062382
2009-03-05

EXTERNAL PREPARATION FOR IMPROVING COITAL FUNCTION

#449
20090048293
2009-02-19

METHODS FOR TREATING BACILLUS INFECTION

#450
20090029921
2009-01-29

Method for removing endotoxin from proteins

#451
20090029005
2009-01-29

Anti-hypertensive functional food products

#452
20090023893
2009-01-22

USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS

#453
20090011046
2009-01-08

Composition Comprising Silver Nanoparticles and the Use Thereof

#454
20080306248
2008-12-11

Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof

#455
20080295188
2008-11-27

Method of screening for substances which proliferate natural killer cells

#456
20080287365
2008-11-20

Method for proliferating natural killer cells

#457
20080274095
2008-11-06

Biocides

#458
20080254079
2008-10-16

Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology

#459
20080227138
2008-09-18

Methods to increase or decrease bone density

#460
20080213283
2008-09-04

Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus

#461
20080208167
2008-08-28

METHODS AND COMPOSITIONS TO TREAT MYOCARDIAL CONDITIONS

#462
20080207531
2008-08-28

Milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases

#463
20080207491
2008-08-28

Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections

#464
20080199458
2008-08-21

INFLUENZA PREVENTION AND TREATMENT COMPOSITION

#465
20080194518
2008-08-14

Antimicrobial Compositions

#466
20080193551
2008-08-14

Dermatologic use of milk proteins

#467
20080153921
2008-06-26

Lycopene Formulations For the Treatment of Atherosclerotic Conditions

#468
20080119542
2008-05-22

METHODS OF USING ARTEMISININ-LIKE COMPOUNDS TO PREVENT OR DELAY THE APPEARANCE OF CANCER

#469
20080070833
2008-03-20

Lactoferrin in the reduction of pain

#470
20080044544
2008-02-21

Milk protein isolate and process for its preparation

#471
20080044397
2008-02-21

Alkaline phosphatase compositions to reduce skin cancer

#472
20080038320
2008-02-14

COMPOSITIONS AND METHODS FOR ENHANCING VASODILATION

#473
20080014270
2008-01-17

METHODS FOR IMPROVED LIPID METABOLISM AND BASAL METABOLIC RATE WITH LACTOFERRIN

#474
20070292496
2007-12-20

Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics

#475
20070264249
2007-11-15

Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases

#476
20070253941
2007-11-01

Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof

#477
20070207963
2007-09-06

USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS

#478
20070207116
2007-09-06

Antioxidant compositions for the eye

#479
20070202600
2007-08-30

Transfection reagents

#480
20070202598
2007-08-30

Transfection reagents

#481
20070202189
2007-08-30

Acellular bioabsorbable tissue regeneration matrices

#482
20070191264
2007-08-16

Methods for inhibiting the growth of bacteria

#483
20070179084
2007-08-02

Process for reducing the concentration of blood glucose in a diabetic patient

#484
20070178172
2007-08-02

Composition for reducing blood lipids

#485
20070172474
2007-07-26

Dairy components effective for fat loss

#486
20070167365
2007-07-19

Compositions for modulating blood-brain barrier transport

#487
20070166711
2007-07-19

Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof

#488
20070165829
2007-07-19

Personal Communication Center Performance Display and Status Alert System

#489
20070161541
2007-07-12

Insult induced immune dissonance

#490
20070160609
2007-07-12

Interferon antagonists useful for the treatment of interferon related diseases

#491
20070149440
2007-06-28

TRANSFERRIN AND TRANSFERRIN-BASED COMPOSITIONS FOR DIABETES TREATMENT

#492
20070148140
2007-06-28

COMPOSITIONS AND METHODS TO ENHANCE VIABILITY AND FUNCTION OF ISLET CELLS

#493
20070134298
2007-06-14

DIETARY SUPPLEMENT

#494
20070116750
2007-05-24

Compositions for disrupting and inhibiting reconstitution of wound biofilm

#495
20070116698
2007-05-24

Novel methods and medicament for treating infectious diseases involving microbial biofilms

#496
20070116675
2007-05-24

Drug and method for proliferating natural killer cells

#497
20070110758
2007-05-17

Method for inhibiting bacterial colonisation

#498
20070104722
2007-05-10

Targeted biocides

#499
20070104711
2007-05-10

Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus

#500
20070085059
2007-04-19

Bioactive complexes compositions and methods of use thereof

#501
20070082065
2007-04-12

Therapeutic composition for the treatment of dry eye syndrome

#502
20070065498
2007-03-22

Encapsulated arsenic drugs

#503
20070059300
2007-03-15

COMPOUNDS AND COMPOSITIONS TO CONTROL ABNORMAL CELL GROWTH

#504
20070053894
2007-03-08

Compound and method for regulating plasminogen activation and cell migration

#505
20070026485
2007-02-01

Glycopegylation methods and proteins/peptides produced by the methods

#506
20070020219
2007-01-25

Method for promoting hair growth

#507
20070014777
2007-01-18

Protein compositions for promoting wound healing and skin regeneration

#508
20070010426
2007-01-11

Composition for preventing and treating cardiovascular disorders

#509
20070009609
2007-01-11

Solid compositions containing combinations of lactoferrin, colostrum, and citrus pectin

#510
20070004617
2007-01-04

Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments

#511
20060286086
2006-12-21

Lysozyme-based food stuff

#512
20060276761
2006-12-07

Storage and delivery vessel for two-part medicament

#513
20060275278
2006-12-07

Method and ophthalmic formulation for eye protection or treatment

#514
20060269535
2006-11-30

Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy

#515
20060264353
2006-11-23

Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension

#516
20060240116
2006-10-26

Bioactive factors in wound healing topical compositions and methods

#517
20060205634
2006-09-14

Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease

#518
20060204549
2006-09-14

Method of improving nutrient utilisation by a mammal and a composition for use therein

#519
20060189695
2006-08-24

External preparation for improving coital function

#520
20060189513
2006-08-24

Lactoferrin in the treatment of diabetes mellitus

#521
20060182260
2006-08-17

Personal communication center performance display and status alert system

#522
20060147442
2006-07-06

Biocides

#523
20060142183
2006-06-29

Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections

#524
20060142179
2006-06-29

4-aminopyridine and a pharmaceutical composition for treatment of neuronal disorders

#525
20060130158
2006-06-15

Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains

#526
20060088600
2006-04-27

Treatment for dry eye syndrome

#527
20060073497
2006-04-06

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

#528
20060040025
2006-02-23

Milk protein isolate and method for preparing same

#529
20060034820
2006-02-16

Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis

#530
20060030519
2006-02-09

Composition for reducing blood lipids

#531
20060029563
2006-02-09

Cutanceous metabolic bio-activator

#532
20050281772
2005-12-22

Compositions for mucosal delivery of agents

#533
20050271603
2005-12-08

Compositions comprising lactoferrin

#534
20050260597
2005-11-24

Transfection reagents

#535
20050244369
2005-11-03

Dietary supplement

#536
20050233950
2005-10-20

Synergistic antimicrobial compositions and methods for reducing biofilm formation

#537
20050222007
2005-10-06

Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences

#538
20050220791
2005-10-06

Novel of cytokine inhibitors

#539
20050164972
2005-07-28

Transfection reagents

#540
20050164971
2005-07-28

New transfection reagents

#541
20050164391
2005-07-28

Transfection reagents

#542
20050163825
2005-07-28

Lactoferrin-treated filament materials

#543
20050159340
2005-07-21

Lactoferrin for age related disorders in humans

#544
20050143286
2005-06-30

Methods of inhibiting and treating bacterial biofilms by metal chelators

#545
20050124069
2005-06-09

Transfection reagents

#546
20050119162
2005-06-02

Analgesics

#547
20050107287
2005-05-19

Treatment of cancers by inhalation of stable platinum-containing formulations

#548
20050075277
2005-04-07

Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

#549
20050064015
2005-03-24

Methods and compositions for use in pet breeding

#550
20050025837
2005-02-03

Solid compositions containing combinations of lactoferrin, colostrum, and citrus pectin

#551
20050020484
2005-01-27

Compositions for improving lipid metabolism

#552
20050004006
2005-01-06

Lactoferrin in the treatment of diabetes mellitus

#553
16733714
2024-09-03

Anti-microbial and anti-inflammatory compositions and methods for treating enteric diseases in animals